SEK836.7m market cap

SEK11.22 last close

Brighter is a Swedish healthtech company focused on the development and commercialisation of self-monitoring and self-treatment health solutions for diabetes.

Investment summary

Brighter is a healthtech company developing solutions for chronic diseases. Its initial strategy is the launch of Actiste, a mobile-connected glucose meter and insulin injection device for diabetes, which the company has submitted for CE certification. Its CE-marked cloud-based platform called the Benefit Loop and associated companion applications collect, manage and analyse data for the purpose of sharing critical treatment information with friends, relatives, caregivers and healthcare providers in an effort to improve self-management outcomes.

Y/E Dec
Revenue (SEKm)
EPS (öre)
P/E (x)
P/CF (x)
2016A 3.3 (17.3) (18.7) (23.53) N/A N/A
2017A 1.4 (19.7) (22.8) (42.01) N/A N/A
2018E 2.1 (30.0) (33.8) (51.32) N/A N/A
2019E 9.2 (49.4) (53.5) (75.49) N/A N/A
Last updated on 19/02/2019
Industry outlook

In 2017, costs attributed to diagnosed diabetes and associated complications, such as cardiovascular disease and nephropathy, totalled $327bn in the US. Patient opinions of treatment burden are heavily correlated with adherence to self-care.

Last updated on 19/02/2019
Share price graph
Balance sheet
Forecast net debt (SEKm) 11
Forecast gearing ratio (%) 15
Price performance
Actual 38.9 12.9 38.6
Relative* 32.4 6.5 33.9
52-week high/low SEK14.9/SEK6.3
*% relative to local index
Key management
Truls Sjostedt CEO
Henrik Norström Chief Operating Officer
Petra Kaur Chief Marketing and Communications Officer